Silence Therapeutics (SLN) Short-term Investments (2020 - 2026)

Silence Therapeutics' Short-term Investments history runs 7 years deep, the most recent figure standing at $64.4 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 10.09% year-over-year to $64.4 million; the TTM figure through Mar 2026 stood at $64.4 million (down 10.09% YoY), while the FY2025 annual figure was $73.8 million, up 14.05% from the prior year.
• Short-term Investments came in at $64.4 million for Q1 2026 at Silence Therapeutics, down from $73.8 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $87.1 million in Q3 2024 to a low of $334707.7 in Q3 2022.
• A 5-year average of $36.6 million and a median of $25.7 million in 2023 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments tumbled 98.16% in 2023 and soared 24112.36% in 2024, its largest moves.
• Silence Therapeutics' Short-term Investments stood at $19.2 million in 2022, then sank by 98.16% to $352487.1 in 2023, then jumped by 18266.63% to $64.7 million in 2024, then advanced by 14.05% to $73.8 million in 2025, then fell by 12.75% to $64.4 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $64.4 million, $73.8 million, and $20.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison